Oxidative stress, Mitochondrial dysfunction and Neuro-degenerative diseases: A Review

Authors

  • Shalini K. Sawhney ITS College of Pharmacy, Muradnagar, Ghaziabad, India

DOI:

https://doi.org/10.21276/IJRDPL.2278-0238.2019.8(1).1-5

Keywords:

Neurodegenerative diseases, Oxidative stress, Mitochondrial dysfunction, Parkinsons's Diseases, Alzheimer's Diseases

Abstract

Oxidative stress is produced by the reactive oxygen/nitrogen species (ROS/RNS) which involves mitochondrial dysfunction. Mitochondria is one of the main sources of oxidative stress, as it utilizes the oxygen for the energy production. Overproduction of ROS, results in oxidative stress, which injures the cell structures, lipids, proteins, and DNA. Various oxidative events implicated in many diseases is due to oxidative stress which include alteration in mitochondrial proteins, mitochondrial lipids and mitochondrial DNA, which in turn leads to damage nerve cells as they are metabolically very active. Reactive oxygen/nitrogen species at moderate concentrations also play roles in normal physiology of many processes like signalling pathways, induction of mitogenic response and in defence against infectious pathogens. Oxidative stress has been considered to be the main cause in the etiology of neurodegenerative diseases, which includes Parkinson's disease (PD) and Alzheimer's disease (AD). Recent research on the dysfunction and function of PD associated genes has provided new fundamental insights into biochemical pathways that are linked with the disease process This review includes source of free radical generation, mitochondrial dysfunction and the mechanism involved in neurodegenerative diseases which involves both PD as well as in AD. This makes the mitochondria, the main target of PD and AD research

Downloads

Download data is not yet available.

References

Golde TE, Petrucelli L, what kills neurons in neurodegenerative diseases, Molecular Neurodegeneration, 2009; 4(7).

Hung C, Chen Y, Hsieh W, Chiou S, LanKao C, Ageing and neurodegenerative diseases, Ageing Research Reviews 2010; 9: 36-46.

AH Bhat AH et al., Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight, Biomedicine & Pharmacotherapy 2015; 74: 101-110.

Droge W, Free radicals in the physiological control of cell function, Physiol. Rev. 2002;82: 47-95.

Hensley M, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA, Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation, J. Neurosci.1998; 18 (20):8126-8132.

Butterfield DA, Castegna A, Lauderback CM, Drake J, Evidence that amyloid â-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiol. Aging 2002; 23: 655-664.

Dexter DT, Carter CJ, Wells FR, Javoy A, Agid F, Agid Y, Lees A, Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease, J. Neurochem. 1989; 52 (2): 381-389.

Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients, Ann. Neurol. 1998;44 (5): 819-824.

Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RJ, Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis, Ann. Neurol. 1997;42 (4) :644-654.

Valko M, Rhodes CJ, Moncol J, Izakovic MM, Mazur M, Free radicals, metals and antioxidants in oxidative stress-induced cancer, Chem. Biol. Interact. 2006; 160 (1): 1-40.

Valko M, Morris H, Cronin MTD, Metals, toxicity and oxidative stress, Curr. Med. Chem.2005; 12: 1161-1208.

Parthasarathy S, Santanam N, Ramachandran S, Meilhac O, Oxidants and antioxidants in atherogenesis: an appraisal, J. Lipid Res. 1999;40: 2143-2157.

RMcCall M, Frei B, can antioxidant vitamins materially reduce oxidative damage in humans, Free Radical Biology and Medicine 1999; 26(7-8): 1034-1053

Chatterjee M, Saluja R, Kanneganti S, Chinta S, Dikshit M, Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats, Cell. Mol. Biol. 2007; 53 (1): 84-93.

Kovacic P, Pozos RS, Somanathan R, Shangari N, O'Brien PJ, Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships, Curr. Med. Chem. 2005; 12: 2601-2623.

Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J, Role of oxygen radicals in DNA damage and cancer incidence, Mol. Cell. Biochem.2004; 266: 37-56.

Bergendi L, Benes L, Durackova Z, Ferencik M, Chemistry, physiology and pathology of free radicals, Life Sci. 1999;65: 1865-1874.

Klatt P, Lamas S, Regulation of protein function by S glutathiolation in response to oxidative and nitrosative stress, Eur. J. Biochem. 2000; 267:4928-4944.

Ridnour LA, Thomas DD, Mancardi D, Espey MG, Miranda KM, Paolocci N, the chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations, Biol. Chem. 2004; 385 (1): 1-10

Wojda W, Salinska E, Kuznicki J, Calcium ions in neuronal degeneration, IUBMB Life 2008; 60: 575-590.

Zimmermann H, Neurotransmitter release, FEBS Lett.1990; 268: 394-399.

Rizzuto R, Pinton P, Brini M, Chiesa A, Filippin L, Pozzan T, Mitochondria as biosensors of calcium microdomains, Cell Calcium 1999;26: 193-199.

Zucker RS, Calcium and activity-dependent synaptic plasticity, Curr. Opin. Neurobiol.1999; 9: 305-313.

Rizzuto R, Bernardi P, Pozzan T, Mitochondria as all-round players of the calcium game, J. Physiol. 2005; 29 (Pt. 1):37-47.

Soderling TR, CaM-kinases modulators of synaptic plasticity, Curr. Opin. Neurobiol. 2000; 10: 375-380.

Sabatini BL, Maravall M, Svoboda K, Ca (2+) signaling in dendritic spines, Curr. Opin. Neurobiol.2001; 11: 349-356.

Celsi F, Pizzo P, Brini M, Leo S, Fotino C, Pinton P, et al., Mitochondria, calcium and cell death: a deadly triad in neurodegeneration, Biochim. Biophys. Acta 2009; 1787:335-344.

Buchholz JN, Behringer EJ, Pottorf WJ, Pearce WJ, Vanterpool CK, Age-dependent changes in Ca2+ homeostasis in peripheral neurones: implications for changes in function, Aging Cell 2007;6: 285-296.

Shohami E, Beit-Yannai E, Horowitz M, Kohen R, Oxidative stress in closed-head injury: brain antioxidant capacity as an indicator of functional outcome J. Cereb. Blood Flow Metab. 1997;17 (10): 1007-1019.

McKhann GD, Folstein MD, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology 1984;34 (7): 939-944.

Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM, Biochemical and anatomical redistribution of tau protein in Alzheimer's disease, Am. J. Pathol. 1993; 143 (2): 565.

Fukuchi K, Hart M, Li L, Alzheimer's disease and heparin sulfate proteoglycan, Front. Biosci. 1998;3: 327-337.

Bergem AL, Engedal K, Kringlen E, The role of heredity in late-onset Alzheimer disease and vascular dementia: a twin study, Arch. Gen. Psychiatry 1997; 54:264-270.

Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Pedersen NL, Role of genes and environments for explaining Alzheimer disease, Arch. Gen. Psychiatry 2006;63 (2) :168-174.

Raiha I, Kaprio J, Koskenvuo M, Rajala T, Sourander L, Alzheimer's disease in Finnish twins, Lancet 1996;347 (9001): 573-578.

Roberts GW, Nash M, Ince PG, Royston MC, Gentleman SM, On the origin of Alzheimer's disease: a hypothesis, NeuroReport 1993;4 (1) :7-9.

Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol. 1991;30 (4) : 572- 580.

Tomlinson BEC, in: Adams JCH, Duchen (Eds.) LW, Ageing and the dementias in Greenfield's Neuropathologyed, Edward Arnold, London, UK, 1984.

Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, et al., Evidence that the b-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Ab by zinc J. Biol. Chem. 2000; 275 (26) :19439-19442.

Feeney CJ, Frantseva MV, Carlen PL, Pennefather PS, Shulyakova N, Shniffer C, et al., Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices, Brain Res. 2008;1198: 1-15.

Giasson BI, Lee VM, A new link between pesticides and Parkinson's disease, Nat. Neurosci. 2000; 3 (12): 1227-1228.

Halliwell B, Gutteridge JMC, Free Radicals Biology and Medicine, third ed., Oxford University Press, 1999.

Schapira AH, Jenner P, Etiology and pathogenesis of Parkinson's disease, Mov. Disord. 2011; 26: 1049-1055.

Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, et al., Missing pieces in the Parkinson's disease puzzle, Nat. Med. 2010; 16: 653-661.

Slivka A, Cohen G, Hydroxyl radical attack on dopamine, J. Biol. Chem. 1985;260: 15466-15472.

Fornstedt B, Pileblad E, Carlsson A, In vivo autoxidation of dopamine in guinea pig striatum increases with age, J. Neurochem. 1990; 55: 655-659.

Strolin B, Enedetti M, Dostert P, Monoamine oxidase, brain ageing and degenerative diseases, Biochem. Pharmacol. 1989;38 :555-561.

Morgan DG, May PC, Finch CE, Dopamine and serotonin systems in human and rodent brain: effects of age and neurodegenerative disease, J. Am. Geriatr. Soc.1987; 35: 334-345.

Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O, Aging produces a specific pattern of striatal dopamine loss: Implications for the etiology of idiopathic Parkinson's disease, J. Neurochem. 1992; 58: 642-648.

Thannickal TC, Lai YY, Siegel JM, Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease, Brain 2008;131: e87.

Bosco DA, Fowler DM, Zhang Q, Nieva J, Powers ET, Wentworth JR, et al., Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization, Nat. Chem. Biol. 2006;2: 249- 253.

Nakabeppu Y, Tsuchimoto D, Yamaguchi H, Sakumi K, Oxidative damage in nucleic acids and Parkinson's disease, J. Neurosci. Res. 2007; 85: 919-934.

Zeevalk GD, Razmpour R, Bernard LP, Glutathione and Parkinson's disease: is this the elephant in the room?Biomed. Pharmacother. 2008;62: 236-249.

Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, et al., High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease, Nat. Genet. 2006; 38: 515-517.

Müftüoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, Ogüs H, et al., Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations, Mov. Disord. 2004; 19:544-548.

Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, Wacker M, et al., Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice, J. Biol. Chem. 2004;279 :18614-18622.

Ojha A, Saraf S, Jangra M. Neuroprotective Activity of Santalum album Seeds in Sepsis Encephalopathy.

Advances in Pharmaceutical Research, 12 Pages, Vol.2019. 10.36218/APR/9636944.

Published

2020-01-15

How to Cite

Sawhney, S. K. . (2020). Oxidative stress, Mitochondrial dysfunction and Neuro-degenerative diseases: A Review. International Journal of Research and Development in Pharmacy & Life Sciences, 8(1), 01-05. https://doi.org/10.21276/IJRDPL.2278-0238.2019.8(1).1-5